These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4987191)

  • 41. Clinical experience with horse antihuman ALG.
    Starzl TE; Groth CG; Kashiwagi N; Putnam CW; Corman JL; Halgrimson CG; Penn I
    Transplant Proc; 1972 Dec; 4(4):491-5. PubMed ID: 4566793
    [No Abstract]   [Full Text] [Related]  

  • 42. Frequency of allograft renal vascular thrombosis under three immunosuppressive regimens at a single institution.
    Gruber SA; Chavers B; Payne WD; Fryd DS; Canafax DM; Simmons RL; Najarian JS; Matas A
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2139-40. PubMed ID: 2652690
    [No Abstract]   [Full Text] [Related]  

  • 43. Causes of allograft failure in recipients treated with and without antilymphocyte globulin.
    Sheil AG; May J; Rogers JH; Storey BG; Katran DC; Duggin GG; Johnson JR; Stewart JH
    Transplant Proc; 1973 Mar; 5(1):561-5. PubMed ID: 4121179
    [No Abstract]   [Full Text] [Related]  

  • 44. Cell-mediated and humoral immune responses or renal transplant recipients with cytomegalovirus infections.
    Lopez C; Simmons RL; Park BH; Najarian JS; Good RA
    Clin Exp Immunol; 1974 Apr; 16(4):565-73. PubMed ID: 4377553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful renal transplantation in patients with circulating antibody to glomerular basement membrane: report of two cases.
    Couser WG; Wallace A; Monaco AP; Lewis EJ
    Clin Nephrol; 1973; 1(6):381-8. PubMed ID: 4595000
    [No Abstract]   [Full Text] [Related]  

  • 46. Use of ATG in treatment of steroid-resistant rejection.
    Hardy MA; Nowygrod R; Elberg A; Appel G
    Transplantation; 1980 Feb; 29(2):162-4. PubMed ID: 6986690
    [No Abstract]   [Full Text] [Related]  

  • 47. Living-donor liver transplant with an interposition graft of the inferior vena cava for hepatocellular carcinoma: beyond the Milan criteria and within the UCSF criteria.
    Ahn KS; Kang KJ; Kim HT; Kim YH; Park UJ; Lim TJ; Park TJ; Cho WH
    Exp Clin Transplant; 2013 Jun; 11(3):283-6. PubMed ID: 23176663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute rejection following cardiac transplantation. Phonocardiographic and ultrasound observations.
    Schroeder JS; Popp RL; Stinson EB; Dong E; Shumway NE; Harrison DC
    Circulation; 1969 Aug; 40(2):155-64. PubMed ID: 4894372
    [No Abstract]   [Full Text] [Related]  

  • 49. Liver transplantation in man--3, Studies of liver function, histology, and immunosuppressive therapy.
    Williams R; Calne RY; Ansell ID; Ashby BS; Cullum PA; Dawson JL; Eddleston AL; Evans DB; Flute PT; Herbertson PM; Joysey V; McGregor AM; Millard PR; Murray-Lyon IM; Pena JR; Rake MO; Sells RA
    Br Med J; 1969 Jul; 3(5661):12-9. PubMed ID: 4306854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on the decline in immunosuppressive potency of rabbit anti-mouse thymocyte sera raised by repeated immunization of the same rabbit.
    Ponsford FM; Symes MO
    Folia Biol (Praha); 1971; 17(4):227-35. PubMed ID: 5002373
    [No Abstract]   [Full Text] [Related]  

  • 51. Serum -fetoprotein in hepatoma patients after liver transplantation.
    Alpert E; Starzl TE; Schur PH; Isselbacher KJ
    Gastroenterology; 1971 Aug; 61(2):144-8. PubMed ID: 4104962
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical transplantation--an overview.
    Kountz SL
    Transplant Proc; 1973 Mar; 5(1):59-65. PubMed ID: 4572118
    [No Abstract]   [Full Text] [Related]  

  • 53. Synergistic immunosuppressive action of antithymocyte antisera and thymectomy in the human.
    Pirofsky B; Reid RR; Ramirez-Mateos JC; Bardana EJ; August A
    Clin Exp Immunol; 1972 Sep; 12(1):89-101. PubMed ID: 4117276
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in serum immunoglobulin and complement levels following renal homotransplantation.
    Levine PH; Merrill DA; Kohler PF; Claman HN
    Transplantation; 1970 Aug; 10(2):141-54. PubMed ID: 4915554
    [No Abstract]   [Full Text] [Related]  

  • 55. Quadruple induction immunosuppression after liver transplantation with interleukin-2 receptor antibody (BT 563) is equally effective and better tolerated than antithymocyte globulin induction therapy.
    Neuhaus P; Bechstein WO; Blumhardt G; Steffen R; Keck H; Lemmens P; Langrehr JM; Schlag H
    Transplant Proc; 1993 Apr; 25(2):1940-1. PubMed ID: 8470234
    [No Abstract]   [Full Text] [Related]  

  • 56. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
    Canafax DM; Savik SK; Draxler CA; Le CT; Ascher NL; Payne WD; Sutherland DE; Migliori RJ; Simmons RL; Najarian JS
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
    [No Abstract]   [Full Text] [Related]  

  • 57. [Renal homotransplantation in men. Results achieved in 37 patients 26 of whom had received antilymphocyte globulins].
    Küss R; Legrain M; Le Gall JR; Guédon J; Poisson J
    J Urol Nephrol (Paris); 1969 Sep; 75(9):594-600. PubMed ID: 4103960
    [No Abstract]   [Full Text] [Related]  

  • 58. The mixed leukocyte response in human renal transplantation.
    Shons AR; Etheredge EE; Schmidtke JR; Najarian JS
    Transplant Proc; 1973 Mar; 5(1):337-42. PubMed ID: 4266657
    [No Abstract]   [Full Text] [Related]  

  • 59. Hepatitis affecting hemodialysis and transplant patients. Its considerations and consequences.
    Briggs WA; Lazarus JM; Birtch AG; Hampers CL; Hager EB; Merrill JP
    Arch Intern Med; 1973 Jul; 132(1):21-8. PubMed ID: 4577389
    [No Abstract]   [Full Text] [Related]  

  • 60. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E; Robinson C; Bear R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.